UNSPSC 51386015: Tazeprofen

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S05RV1R3LZ. European Medicines Agency schedules Tazeprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10846MIG. Tazeprofen generally arises in the molecular formula C16H13NO2S.

UNSPSC 51386015 Tazeprofen is a Commodity code, but the recent solicitation activity under this code shows a substantial mismatch: the single recorded opportunity tags a procurement for naloxone and drug deactivation systems, which falls outside the nominal scope of tazeprofen (an NSAID pain reliever). The source provides no evidence of state and local governments actually soliciting tazeprofen through this code classification. State and local procurement does purchase pharmaceuticals and medical supplies through UNSPSC codes, but the available record does not support active demand for tazeprofen specifically under this commodity designation.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The contract carries a two-year initial term plus one optional year, includes FEMA compliance requirements, and mandates E-Verify, drug-free workplace certification, and standard insurance coverage. This opportunity is misclassified under the tazeprofen code and does not reflect actual procurement demand for the pharmaceutical. The code shows little relevant recent activity for business development targeting.